Correlação de três variáveis na descrição da permeabilidade nasal (HD, MCA, escala NOSE) de pacientes saudáveis Correlation of three variables describing nasal patency (HD, MCA, NO...

by Thomas Braun, Maria Rich, Matthias F. Kramer
Published 2013-06-01

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)

by Matthew D. Heath, Matthew D. Heath, Mona O. Mohsen, Mona O. Mohsen, Pieter-Jan de Kam, Thalia L. Carreno Velazquez, Simon J. Hewings, Simon J. Hewings, Matthias F. Kramer, Matthias F. Kramer, Thomas M. Kündig, Martin F. Bachmann, Martin F. Bachmann, Murray A. Skinner, Murray A. Skinner
Published 2020-11-01

First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients

by Karl-Christian Bergmann, Linda Krause, Julia Hiller, Sylvia Becker, Sebastian Kugler, Martin Tapparo, Oliver Pfaar, Torsten Zuberbier, Matthias F. Kramer, Sonja Guethoff, Anke Graessel
Published 2021-01-01

The grass pollen season 2015: a proof of concept multi-approach study in three different European cities

by Maximilian Kmenta, Katharina Bastl, Uwe Berger, Matthias F. Kramer, Matthew D. Heath, Sanna Pätsi, Anna-Mari Pessi, Annika Saarto, Barbora Werchan, Matthias Werchan, Reinhard Zetter, Karl-Christian Bergmann
Published 2017-09-01

The grass pollen season 2015: a proof of concept multi-approach study in three different European cities

by Maximilian Kmenta, Katharina Bastl, Uwe Berger, Matthias F. Kramer, Matthew D. Heath, Sanna Pätsi, Anna-Mari Pessi, Annika Saarto, Barbora Werchan, Matthias Werchan, Reinhard Zetter, Karl-Christian Bergmann
Published 2017-01-01

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season

by Ralph Mösges, Nils Y. Breitrück, Silke Allekotte, Kija Shah-Hosseini, Van-Anh Dao, Petra Zieglmayer, Katrin Birkholz, Mark Hess, Maximilian Bastl, Katharina Bastl, Uwe Berger, Matthias F. Kramer, Sonja Guethoff
Published 2019-01-01

Correction:<em> Zika Virus</em>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <em>Dengue Virus</...

by Gustavo Cabral-Miranda, Stephanie M. Lim, Mona O. Mohsen, Ilya V. Pobelov, Elisa S. Roesti, Matthew D. Heath, Murray A. Skinner, Matthias F. Kramer, Byron E.E Martina, Martin F. Bachmann
Published 2020-02-01

<i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> Infection

by Gustavo Cabral-Miranda, Stephanie M. Lim, Mona O. Mohsen, Ilya V. Pobelov, Elisa S. Roesti, Matthew D. Heath, Murray A. Skinner, Matthias F. Kramer, Byron E. E. Martina, Martin F. Bachmann
Published 2019-07-01

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria

by Gustavo Cabral-Miranda, Matthew D. Heath, Ariane C. Gomes, Mona O. Mohsen, Eduardo Montoya-Diaz, Ahmed M. Salman, Erwan Atcheson, Murray A. Skinner, Matthias F. Kramer, Arturo Reyes-Sandoval, Martin F. Bachmann
Published 2017-09-01

Venom Immunotherapy: From Proteins to Product to Patient Protection

by Martin Feindor, Matthew D. Heath, Simon J. Hewings, Thalia L. Carreno Velazquez, Simon Blank, Johannes Grosch, Thilo Jakob, Peter Schmid-Grendelmeier, Ludger Klimek, David B. K. Golden, Murray A. Skinner, Matthias F. Kramer
Published 2021-09-01

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vi...

by Gustavo Cabral-Miranda, Matthew D. Heath, Mona O. Mohsen, Ariane C. Gomes, Paul Engeroff, Amy Flaxman, Fabiana M. S. Leoratti, Aadil El-Turabi, Arturo Reyes-Sandoval, Murray A. Skinner, Matthias F. Kramer, Martin F. Bachmann
Published 2017-05-01

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

by Gustavo Cabral-Miranda, Ahmed M. Salman, Mona O. Mohsen, Federico L. Storni, Elisa S. Roesti, Murray A. Skinner, Matthew D. Heath, Matthias F. Kramer, Shahid M. Khan, Chris J. Janse, Adrian V. S. Hill, Martin F. Bachmann
Published 2018-11-01

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

by Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins, Marcos Sande, Jens V. Stein, Carsten Riether, Elisa Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kundig, Monique Vogel, Murray A. Skinner, Daniel E. Speiser, Alexander Knuth, Matthias F. Kramer, Martin F. Bachmann
Published 2019-04-01

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

by Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins, Marcos Sande, Jens V. Stein, Carsten Riether, Elisa Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kundig, Monique Vogel, Murray A. Skinner, Daniel E. Speiser, Alexander Knuth, Matthias F. Kramer, Martin F. Bachmann
Published 2019-05-01

Dogmas, challenges, and promises in phase III allergen immunotherapy studies

by Pieter-Jan De Kam, PhD, Matthias F. Kramer, MD, Mohamed H. Shamji, PhD, Kemi Oluwayi, MD, Matthew D. Heath, PhD, Erika Jensen-Jarolim, MD, Markus H. Berger, MD, Uwe E. Berger, MBA, Anke Graessel, PhD, Fiona Sellwood, Stefan Zielen, MD, Christian Vogelberg, MD, Petra Zieglmayer, MD, Ralph Mösges, MD, PhD, Ludger Klimek, MD, PhD, Lawrence M. DuBuske, MD, Wayne G. Shreffler, MD, PhD, Jonathan A. Bernstein, MD, Thomas M. Kündig, MD, Murray A. Skinner, PhD
Published 2021-09-01